I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 29 studies | 33% ± 11% | |
| classical monocyte | 26 studies | 56% ± 18% | |
| non-classical monocyte | 25 studies | 63% ± 18% | |
| monocyte | 23 studies | 40% ± 13% | |
| conventional dendritic cell | 22 studies | 38% ± 18% | |
| macrophage | 16 studies | 29% ± 11% | |
| CD16-positive, CD56-dim natural killer cell, human | 14 studies | 43% ± 15% | |
| dendritic cell | 14 studies | 36% ± 17% | |
| CD16-negative, CD56-bright natural killer cell, human | 13 studies | 31% ± 13% | |
| myeloid cell | 10 studies | 40% ± 23% | |
| B cell | 9 studies | 29% ± 15% | |
| mature NK T cell | 9 studies | 29% ± 10% | |
| neutrophil | 9 studies | 40% ± 16% | |
| alveolar macrophage | 7 studies | 37% ± 5% | |
| gamma-delta T cell | 7 studies | 22% ± 5% | |
| CD8-positive, alpha-beta T cell | 5 studies | 22% ± 4% | |
| mononuclear phagocyte | 4 studies | 32% ± 17% | |
| intermediate monocyte | 4 studies | 73% ± 21% | |
| memory B cell | 4 studies | 23% ± 6% | |
| innate lymphoid cell | 3 studies | 34% ± 8% | |
| effector memory CD8-positive, alpha-beta T cell, terminally differentiated | 3 studies | 20% ± 3% |
